Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tomokazu Nagashima"'
Autor:
Yuyo Yasumura, Takahiro Teshima, Tomokazu Nagashima, Masaki Michishita, Yoshiaki Taira, Ryohei Suzuki, Hirotaka Matsumoto
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
IntroductionThe therapeutic efficacy of mesenchymal stromal cells (MSCs) in inflammatory bowel disease is not completely known and is not consistent. Priming with inflammatory cytokines has been proposed to adapt MSCs to an inflammatory environment t
Externí odkaz:
https://doaj.org/article/fafd6528a5a8495db4b76faf7ceee651
Autor:
Yuyo Yasumura, Takahiro Teshima, Tomokazu Nagashima, Masaki Michishita, Takashi Takano, Yoshiaki Taira, Ryohei Suzuki, Hirotaka Matsumoto
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17484 (2023)
Mesenchymal stem cells (MSCs) are a promising cell source for stem cell therapy of intractable diseases in veterinary medicine, but donor-dependent cellular heterogeneity is an issue that influences therapeutic efficacy. Thus, we previously establish
Externí odkaz:
https://doaj.org/article/ed8bf7af7fda414d811a7df01f337b7d
Publikováno v:
Frontiers in Veterinary Science, Vol 10 (2023)
Chondrosarcoma is the second most common primary bone tumor after osteosarcoma in dogs. Chondrosarcoma has a good prognosis owing to its low metastatic rate and long survival time, even with amputation alone. However, amputation risks reducing the qu
Externí odkaz:
https://doaj.org/article/294577cec93442de84731f82d2063ab9
Autor:
Masaki Michishita, Kazuhiko Ochiai, Rei Nakahira, Daigo Azakami, Yukino Machida, Tomokazu Nagashima, Takayuki Nakagawa, Toshiyuki Ishiwata
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Mammary adenocarcinoma, the most common cancer in female dogs, often exhibits the lymph node and lung metastases and has a higher mortality rate. However, mammary adenocarcinoma has no established treatment, except early surgical excision. Canine mam
Externí odkaz:
https://doaj.org/article/68c192b5ca1742e498e9e51c465cf965
Autor:
Hiroyuki Tani, Ryo Miyamoto, Syunya Noguchi, Sena Kurita, Tomokazu Nagashima, Masaki Michishita, Naoko Yayoshi, Kyoichi Tamura, Makoto Bonkobara
Publikováno v:
BMC Veterinary Research, Vol 17, Iss 1, Pp 1-7 (2021)
Abstract Background Canine malignant melanoma is highly aggressive and generally chemoresistant. Toceranib is a kinase inhibitor drug that inhibits several tyrosine kinases including the proto-oncogene receptor tyrosine kinase KIT. Although canine ma
Externí odkaz:
https://doaj.org/article/72bcb6d775514e2fb1f6c607fec8f79b
Autor:
Kento Ishikawa, Tomokazu Nagashima, Yukino Machida, Akiko Yasuda, Karin Yoshida, Michio Fujita, Kazuhiko Ochiai, Daigo Azakami, Masaki Michishita
Publikováno v:
Journal of Feline Medicine and Surgery Open Reports, Vol 8 (2022)
Case summary A 4-year-old castrated male domestic shorthair cat with a continuous cough was brought to a private veterinary clinic for detailed examination. Radiography of the thoracic cavity revealed a severe radiopaque region in the caudal lobe of
Externí odkaz:
https://doaj.org/article/5c7db8b9e81747eba7384971f898bcb2
Autor:
Yuyo Yasumura, Takahiro Teshima, Tomokazu Nagashima, Takashi Takano, Masaki Michishita, Yoshiaki Taira, Ryohei Suzuki, Hirotaka Matsumoto
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 2250 (2023)
Mesenchymal stem cells are expected to be a cell source for stem cell therapy of various diseases in veterinary medicine. However, donor-dependent cell heterogenicity has been a cause of inconsistent therapeutic efficiency. Therefore, we established
Externí odkaz:
https://doaj.org/article/7ddb8ab9802148a0b1c43618c2683c18
Autor:
Takahiro Teshima, Keiji Okamoto, Kazuho Dairaku, Tomokazu Nagashima, Masaki Michishita, Ryohei Suzuki, Hirotaka Matsumoto, Hidekazu Koyama
Publikováno v:
Stem Cells International, Vol 2020 (2020)
The potential of mesenchymal stem cells (MSCs) to differentiate into nonmesodermal cells such as pancreatic beta cells has been reported. New cell-based therapy using MSCs for diabetes mellitus is anticipated as an alternative treatment option to ins
Externí odkaz:
https://doaj.org/article/202c657962694b8e9ead5eba969a6430
Autor:
Takahiro Teshima, Hirotaka Matsumoto, Masaki Michishita, Akito Matsuoka, Maika Shiba, Tomokazu Nagashima, Hidekazu Koyama
Publikováno v:
Stem Cells International, Vol 2017 (2017)
Adipose tissue-derived mesenchymal stem cells (AT-MSCs) are an attractive source for cell-based therapy of some diseases, including acute and chronic liver failure, in not only human medicine but also veterinary medicine. However, in veterinary medic
Externí odkaz:
https://doaj.org/article/f2669470ff5b4fe0bc5f9c11e6b90e9a
Publikováno v:
Veterinary Research Forum; May2024, Vol. 15 Issue 5, p257-260, 4p